Back to Search Start Over

Inflammation Markers Among Schizophrenia Patients Who Use Cannabis.

Authors :
Fridman J
Bloemhof-Bris E
Weizman S
Kessler T
Porat D
Ivry A
Wolf A
Stryjer R
Shelef A
Source :
Clinical neuropharmacology [Clin Neuropharmacol] 2023 Jun 20. Date of Electronic Publication: 2023 Jun 20.
Publication Year :
2023
Publisher :
Ahead of Print

Abstract

Objectives: The mechanism of inflammation of the immune system, for example, such circulatory markers as the neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume (MPV), has been shown in many studies to be associated with schizophrenia. In addition, it has been shown that the cannabidiol component reduces the activation of the acquired immune system. This study examined the differences in the levels of NLR and MPV among schizophrenia patients with cannabis use versus those without.<br />Methods: In 2019 to 2020, a retrospective cross-sectional study was conducted based on digital medical records. Demographic, clinical, and complete blood cell count data were collected from records of rehospitalization of active psychotic schizophrenia inpatients. Data on NLR, MPV values, and demographic and clinical characteristics were compared between the groups and according to the degree of prevalence of cannabis use.<br />Results: No differences were found in the NLR and MPV values between the groups.<br />Conclusion: The results were contrary to our expectations. These results may be explained by the presentation of a "pseudo-balanced" picture created when multiple processes affect inflammatory indices.<br />Competing Interests: Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare.<br /> (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1537-162X
Database :
MEDLINE
Journal :
Clinical neuropharmacology
Publication Type :
Academic Journal
Accession number :
37335845
Full Text :
https://doi.org/10.1097/WNF.0000000000000558